GBI Research Market Research Reports

Title published price

Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

By GBI Research

Summary Kidneys are highly specialized organs that maintain a stable internal environment of the body - referred to as homeostasis - by selectively excreting, retaining and secreting various substances according to specifi ...

03-Oct-2017 $6995

Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs

By GBI Research

Summary Ophthalmology is a therapy area that encompasses the diagnosis, treatment and prevention of diseases associated with the eyes and the visual system. The visual system, including the eye and its surrounding structur ...

01-Oct-2017 $6995

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

By GBI Research

Diabetes mellitus refers to a group of metabolic diseases characterized by chronic hyperglycemia (high blood glucose levels) that results from defects in insulin secretion, insulin action, or both (ADA, 2014b). Insulin is a hormone that contribute ...

01-Oct-2017 $4995

Pneumonia Drug Development Pipeline Review, 2017

By GBI Research

Pneumonia Drug Development Pipeline Review, 2017 Summary Community acquired pneumonia refers to pneumonia contracted by a person who has had little contact with the healthcare system. There are a total of 20 products in deve ...

26-Sep-2017 $3995

Sleep Disorders Drug Development Pipeline Review, 2017

By GBI Research

Sleep Disorders Drug Development Pipeline Review, 2017 Summary Restless legs syndrome is characterized by a distressing, irresistible need or urge to move the legs. There are a total of eight products in development for this ...

26-Sep-2017 $3995

Male Health Drug Development Pipeline Review, 2017

By GBI Research

Male Health Drug Development Pipeline Review, 2017 Summary Male hypogonadism is characterized by androgen deficiency and infertility. Hypogonadism can be caused by disorders at the hypothalamic or pituitary level (hypogonado ...

25-Sep-2017 $3995

Colorectal Cancer Drug Development Pipeline Review, 2017

By GBI Research

Colorectal Cancer Drug Development Pipeline Review, 2017 Summary Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal ...

22-Sep-2017 $3995

Behavioral Disorders Drug Development Pipeline Review, 2017

By GBI Research

Behavioral Disorders Drug Development Pipeline Review, 2017 Summary Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communicati ...

14-Sep-2017 $3995

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes

By GBI Research

Summary Diabetes mellitus (DM) is a generalized term used to define multiple diseases with different etiologies that are characterized by chronic hyperglycemia (high blood glucose levels) resulting from insufficient synthe ...

13-Sep-2017 $4995

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

By GBI Research

Summary Respiratory disorders, which affect components of the respiratory system such as the lungs and airway, are a broad range of chronic diseases with a variety of underlying causes, ranging from inherited mutations to ...

01-Sep-2017 $4995

Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets

By GBI Research

Summary Cancer is a group of diseases that are defined by abnormal cell growth, local tissue invasion and eventual migration to other parts of the body. The diseases are driven by the accumulation of genetic mutations, whi ...

01-Sep-2017 $6995

Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017

By GBI Research

Summary Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults, with the most common form being Stargardt disease, an inherited autosomal recessive syndrome.There are a ...

01-Aug-2017 $3995

Hepatitis Drug Development Pipeline Review, 2017

By GBI Research

Summary Hepatitis is a contagious viral infection affecting the liver, which may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. ...

01-Aug-2017 $3995

Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017

By GBI Research

Summary Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness, with symptoms including disorganized work habits, procrastination and ...

01-Aug-2017 $3995

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

By GBI Research

Summary Oncology comprises a large and diverse group of indications, encompassing virtually all sites and tissues in the human body. The diseases are characterized by abnormal cell proliferation, which is followed by local ...

13-Jul-2017 $4995

Pain Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the pain pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Osteoarth ...

01-Jul-2017 $3995

Skeletal Disease Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development f ...

01-Jul-2017 $3995

Transplantation Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive inf ...

01-Jul-2017 $3995

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

By GBI Research

Summary Colorectal cancer (CRC) originates in either the colon or the rectum. It is one of the most common types of cancers, and is the third most common cancer among men and the second most common in women (ACS, 2017a; Fe ...

01-Jul-2017 $4995

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

By GBI Research

Summary Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist, ranging from the autoimmune disorder psoriasis ...

01-Jul-2017 $4995